In this video, Catherine S. Diefenbach, MD, discusses the differences between three FDA-approved CD19-directed chimeric antigen receptor T-cell therapy products for the treatment of lymphoma.

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

If you live in the United States, odds are high that a tiny passenger rides in your blood. By adulthood, more than 94 percent ...

During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

A new international multicenter study published in the Journal of Cellular and Molecular Medicine provides important real-world evidence on the use of CD19-targeted chimeric antigen receptor (CAR) ...

In a town on the shores of Lake Geneva sit clumps of living human brain cells for hire. These blobs, about the size of a ...

A peek inside some leading research labs shows how scientists-turned-detectives are painstakingly decoding what causes ...

Early CAR T cell expansion is associated with both therapeutic activity and inflammatory toxicity, such as cytokine release syndrome and neurotoxicity. Routine flow cytometry can reliably track ...

Charles Longshore distinctly remembers the tipping point that led his Alabama middle school to ban cell phones, two years ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

Laws are not meant to be broken but that doesn't mean they can't be bent or twisted a little bit to perfectly fit a given ...